Close Menu

Going for the Gold

Graduate student Geoffrey von Maltzahn has been using gold nanoparticles to develop new methods to fight cancer. One takes advantage of the porous blood vessels that tumors put out to get gold rod-shaped nanoparticles into tumors. Once there, von Maltzahn shines a near-infrared laser on the patient's skin, above the tumor, to heat up the gold and destroy the malignant tissue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.